| Literature DB >> 15686939 |
Jens Pohlmann1, Thomas Lampe, Mitsuyuki Shimada, Peter G Nell, Josef Pernerstorfer, Niels Svenstrup, Nina A Brunner, Guido Schiffer, Christoph Freiberg.
Abstract
The pseudopeptide pyrrolidinedione natural products moiramide B and andrimid represent a new class of antibiotics that target bacterial fatty acid biosynthesis. Structure-activity relationship (SAR) studies revealed a high degree of variability for the fatty acid side chain, allowing optimization of physicochemical parameters, and a restricted SAR for the pyrrolidinedione group, indicating major relevance of this subunit for efficient target binding.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15686939 DOI: 10.1016/j.bmcl.2004.12.002
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823